Background—Chronic kidney disease (CKD) is an established risk factor for poor outcomes
in heart failure (HF). Whether proteinuria provides additional prognostic information is not …

Background The aim of the present study was to assess the short-and long-term effects of
multiple doses of the angiotensin II receptor antagonist losartan in heart failure. Methods …

OBJECTIVES We sought to prospectively and randomly compare survival with clinical and
hemodynamic variables in patients with congestive heart failure (CHF) treated with standard …

Objectives: The objective of the study was to evaluate the effect of an angiotensin receptor
blocker on left ventricular (LV) structure and function when added to prescribed heart failure …

Background In patients with symptomatic heart failure, sacubitril–valsartan has been found
to reduce the risk of hospitalization and death from cardiovascular causes more effectively …

A randomized, parallel, double-blind study was performed with lisinopril, a long-acting
angiotensin-converting enzyme inhibitor, versus captopril, a shorter-acting angiotensin …

Background Angiotensin II type 1 receptor blockers have favourable effects on
haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when …

Background Angiotensin converting-enzyme (ACE) inhibitors used for the treatment of heart
failure relieve symptoms, increase exercise performance, reduce hospital admissions and …